Receiving an adverse event report is an important part of drug safety monitoring, but it’s rarely the end of the conversation. The safety team may need additional information. When did the symptoms begin? Was the medicine stopped? Did the patient recover? Was any treatment required? Were other products being taken at the same time?
Later, the organization may need to communicate in the other direction by sharing an updated warning, revised instructions, risk-minimization materials, or new guidance for healthcare professionals. In a global environment, many of these conversations cross languages.
Their success depends not only on whether the words are translated accurately, but also on whether patients and healthcare professionals understand what’s being asked and what they may need to do next.
Safety information must move in both directions
Drug safety monitoring depends on information flowing from patients and healthcare professionals into the safety system. But the process also requires organizations to communicate back. A team may need to request missing information, confirm the timing of an event, clarify a dosage, or ask about the patient’s recovery. It may also need to distribute updated product information, provide instructions for monitoring an identified risk, or explain when medical advice should be sought.
This creates a communication loop:
- An experience is reported.
- The safety team reviews the information.
- Follow-up questions are sent where needed.
- Additional information is received and added to the case.
- Relevant safety findings or actions are communicated.
Each stage depends on clear language. When a question is confusing, overly technical, or poorly adapted for its audience, the response may be incomplete. When translated information is handled without the context of the original case, useful details may become disconnected.
Asking the right question isn’t enough
Safety professionals may know exactly what information they require, but the wording of a question can affect the answer.
A phrase such as: ‘Please confirm the latency between product administration and event onset’ may be familiar to a safety professional, but it is unlikely to be the clearest wording for a patient. A more direct version might ask: ‘How much time passed between taking the medicine and first noticing the symptoms?’
The underlying question is the same, but the second version is easier to understand.
Translation does not automatically fix unclear source content. If a complicated question is translated just as complicatedly, the recipient may still struggle to answer.
Effective multilingual communication begins with source content that’s direct, well structured, and appropriate for the intended reader.
Patients and healthcare professionals need different approaches
Drug safety information may be shared with patients, caregivers, physicians, pharmacists, nurses, investigators, and other healthcare professionals. These audiences don’t always need the same level of detail or style of communication.
Healthcare professionals may require clinical terminology, prescribing information, contraindications, monitoring requirements, and detailed instructions for managing or reporting an identified risk.
Patients need the information presented in a way that helps them understand:
- What the risk is
- Which symptoms to watch for
- What action they should take
- When they should contact a healthcare professional
- Where they can find additional help
That doesn’t mean removing important information. It means presenting it in a form the reader can understand and use. A single translation approach will not always work for every audience. Terminology, sentence structure, tone, format, and level of explanation may all need to change. The goal isn’t simply to create matching documents. It’s to communicate the same safety message effectively.
Consistency matters across every channel
Drug safety information may appear across a wide range of materials:
- Patient information and product labeling
- Healthcare professional communications
- Follow-up questionnaires
- Patient alert cards
- Risk-minimization materials
- Call center scripts
- Websites and patient portals
- Emails and letters
- Training materials
- Digital platforms and applications
When these materials are developed by different teams or vendors, wording can begin to drift. A symptom may be described one way in a patient guide and another way in a call center script. An instruction may sound urgent in one language but less urgent in another. Product terminology may differ between printed and digital content. Controlled terminology can help maintain alignment across markets and channels. But consistency is about more than repeating the same words. Teams must also check that the meaning, level of urgency, and required action remain clear in each language.
Clear language supports better responses
Patient-facing safety information can be accurate and still be difficult to understand. Long sentences, dense paragraphs, unfamiliar terminology, and unclear instructions can prevent readers from finding the information they need.
Plain language can make technical content more usable without weakening its accuracy.
Teams can:
- Break long sentences into manageable steps
- Explain unfamiliar terms
- Use descriptive headings
- Place important actions prominently
- Avoid unnecessary abbreviations
- Make clear who should act and when
- Use consistent wording across related materials
The same principles apply across languages, although the solution may not look identical in every market.
Sentence structure, cultural expectations, reading patterns, and available space can vary. A translation should therefore be reviewed as a complete piece of communication, not only checked sentence by sentence.
The key question is not just: Is the translation accurate? It is also: Will the intended reader understand what this means and what they should do next?
Accessibility is part of effective communication
Some patients may require information in another format as well as another language.
Depending on the audience, this may include:
- Large print
- Braille
- Audio
- Accessible digital documents
- Captions
- Screen-reader-compatible content
- Other communication accommodations
Accessibility shouldn’t be treated as a final conversion after the content has already been completed. Decisions about document structure, tables, graphics, headings, and navigation can affect how successfully information can be adapted into different formats. Planning language and accessibility together can reduce repeated work and help organizations provide more consistent safety communications.
Not every conversation happens in writing
Drug safety communication occurs through various channels, including patient support lines, follow-up calls, clinical discussions, and conversations with healthcare professionals. In these situations, qualified interpreters can facilitate more accurate exchanges of information between both parties.
The method of interpretation should depend on the context. For many routine interactions, on-demand phone or video interpretation may be suitable. However, more complex, sensitive, or scheduled conversations may necessitate an interpreter with relevant subject-matter expertise. It’s important to note that the interpreter’s role isn’t to offer medical advice or make safety decisions; rather, it’s to assist in ensuring clear communication among the patient, healthcare professional, and organization.
Make communication part of the safety process
Drug safety teams invest significant effort in collecting, reviewing, and assessing information. The value of that work depends partly on how effectively questions, findings, and actions are communicated.
A strong multilingual communication process should help organizations:
- Ask clear follow-up questions
- Preserve the reporter’s responses accurately
- Adapt content for different audiences
- Maintain terminology across markets
- Coordinate printed and digital materials
- Provide accessible formats
- Track approvals and revisions
- Respond quickly when safety information changes
These activities should not sit at the edge of the pharmacovigilance program. They are part of how safety information becomes action.
Closing the communication loop
Patient safety depends on more than receiving reports. It depends on whether teams can clarify incomplete information, communicate emerging risks, and provide guidance that patients and healthcare professionals understand.
When that communication crosses languages, accuracy remains essential—but accuracy alone is not enough. The message must also be clear, consistent, appropriate for its audience, and available in a usable format.
The strongest multilingual drug safety programs recognize that communication is not a final step. It is the thread connecting reporting, follow-up, assessment, and action.
Clearer multilingual drug safety communications
BIG Language Solutions helps life sciences organizations communicate safety information clearly across languages, markets, audiences, and formats.
Through specialist life sciences translation, interpretation, terminology management, secure multilingual workflows, accessible formats, and human quality review, we help teams maintain accuracy and consistency while making important information easier to understand and act on.
Are your drug safety communications as clear and effective in every language as they are in the original?
Contact BIG Language Solutions to discuss multilingual communication across the drug safety lifecycle.
